The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for K Irie


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.EBI
Ehime University
Structural insights into mechanisms for inhibiting amyloidß42 aggregation by non-catechol-type flavonoids.EBI
Kyoto University
Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.EBI
Kyoto University
Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.EBI
Kyoto University
Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V.EBI
Kyoto University
Generation of 'Unnatural Natural Product' library and identification of a small molecule inhibitor of XIAP.EBI
Keio University
Role of the phenolic hydroxyl group in the biological activities of simplified analogue of aplysiatoxin with antiproliferative activity.EBI
Kyoto University
 
Synthesis and characterization of the second cysteine-rich region of mouse skin PKCGhEBI
TBA
Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymes.EBI
Kyoto University
A simplified analog of debromoaplysiatoxin lacking the B-ring of spiroketal moiety retains protein kinase C-binding and antiproliferative activities.EBI
Kagawa University
Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta.EBI
Kyoto University
Synthesis and binding selectivity of 7- and 15-decylbenzolactone-V8 for the C1 domains of protein kinase C isozymes.EBI
Kyoto University
Synthesis and biological activities of simplified aplysiatoxin analogs focused on the CH/π interaction.EBI
Kyoto University
Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer.EBI
Gifu Pharmaceutical University
The amide hydrogen of (-)-indolactam-V and benzolactam-V8's plays a critical role in protein kinase C binding and tumor-promoting activities.EBI
Kyoto University
The C4 hydroxyl group of phorbol esters is not necessary for protein kinase C binding.EBI
Kyoto University
Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.EBI
Stanford University
Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities.EBI
Kyoto University
Structure-activity studies on the side chain of a simplified analog of aplysiatoxin (aplog-1) with anti-proliferative activity.EBI
Kyoto University
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.EBI
University of Tsukuba
Nitrogen-containing heterocyclic compound and use thereofBDB
Takeda Pharmaceutical